av/cadila-healthcare--big.svg

COM:ZYDUSLIFE

Zydus Lifesciences Ltd.

  • Stock

Last Close

944.05

22/11 10:00

Market Cap

1.17T

Beta: -

Volume Today

295.38K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
12.91B
-
14.52B
12.48%
14.93B
2.88%
16.27B
8.97%
20.95B
28.70%
25.37B
21.11%
27.39B
7.96%
30.13B
10.01%
34.78B
15.44%
35.66B
2.55%
average payables
7.84B
-
10.01B
27.69%
12.18B
21.69%
15.09B
23.92%
17.81B
18.01%
19.05B
6.99%
19.77B
3.74%
21.18B
7.17%
21.72B
2.52%
21.31B
1.86%
average receivables
13.76B
-
16.79B
22.03%
19.72B
17.46%
22.40B
13.60%
30.30B
35.23%
41.93B
38.39%
46.67B
11.32%
44.64B
4.35%
46.91B
5.09%
47.29B
0.81%
book value per share
33.59
-
41.53
23.63%
52.28
25.88%
67.99
30.05%
85.42
25.64%
101.45
18.78%
101.35
0.10%
126.91
25.22%
166.05
30.84%
172.46
3.86%
capex per share
-4.57
-
-5.01
9.44%
-9.49
89.66%
-29.09
206.45%
-10.25
64.77%
-10.33
0.77%
-8.83
14.50%
-8.34
5.54%
-11.75
40.82%
-10.15
13.59%
capex to depreciation
-2.33
-
-1.78
23.36%
-3.22
80.31%
-7.94
146.96%
-1.94
75.55%
-1.77
9.01%
-1.30
26.52%
-1.18
9.23%
-1.63
38.66%
-1.43
12.69%
capex to operating cash flow
-0.53
-
-0.52
2.30%
-0.49
5.49%
-2.21
352.76%
-1.14
48.28%
-0.37
67.86%
-0.36
1.64%
-0.26
28.13%
-0.57
120.39%
-0.38
32.92%
capex to revenue
-0.06
-
-0.06
8.62%
-0.10
66.79%
-0.32
219.71%
-0.09
71.36%
-0.08
8.31%
-0.07
21.08%
-0.06
11.97%
-0.08
40.76%
-0.06
24.69%
cash per share
5.99
-
7.73
29.01%
9.07
17.36%
15.68
72.87%
17.51
11.66%
9.77
44.18%
13.09
33.91%
11.01
15.86%
34.24
210.93%
13.99
59.15%
days of inventory on hand
176.93
-
169.36
4.28%
153.10
9.60%
181.05
18.26%
200.47
10.73%
198.21
1.13%
197.69
0.26%
215.55
9.03%
233.31
8.24%
197.44
15.37%
days payables outstanding
117.84
-
120.31
2.09%
141.88
17.93%
168.00
18.40%
158.71
5.53%
141.77
10.67%
143.96
1.55%
146.93
2.06%
134.10
8.73%
122.92
8.34%
days sales outstanding
73.98
-
79.90
8.01%
76.07
4.80%
94.07
23.66%
114.20
21.39%
136.18
19.25%
120.98
11.16%
107.12
11.45%
123.88
15.65%
95.70
22.74%
debt to assets
0.34
-
0.29
13.33%
0.24
16.81%
0.34
40.32%
0.30
12.52%
0.34
12.40%
0.34
0.58%
0.19
42.98%
0.15
21.28%
0.05
69.45%
debt to equity
0.79
-
0.62
20.58%
0.46
26.83%
0.75
63.97%
0.62
17.36%
0.76
23.01%
0.77
1.55%
0.35
54.08%
0.25
29.99%
0.07
72.53%
dividend yield
0.01
-
0.01
29.41%
0.02
246.04%
0.01
59.49%
0.01
-
0.03
157.62%
0.00
99.87%
0.01
31,292.25%
0.01
48.72%
earnings yield
0.04
-
0.03
15.90%
0.05
45.73%
0.03
29.95%
0.05
37.02%
0.05
16.45%
0.04
18.02%
0.05
9.92%
0.07
37.95%
0.04
39.64%
enterprise value
231.37B
-
376.44B
62.70%
341.89B
9.18%
489.13B
43.07%
435.11B
11.04%
427.21B
1.82%
345.28B
19.18%
490.79B
42.14%
392.41B
20.05%
506.31B
29.03%
enterprise value over ebitda
18.06
-
20.88
15.59%
13.89
33.49%
24.60
77.11%
14.87
39.56%
14.03
5.64%
12.41
11.54%
14.44
16.34%
11.45
20.72%
12.51
9.31%
ev to operating cash flow
26.08
-
37.89
45.24%
17.15
54.74%
36.25
111.37%
47.33
30.58%
14.82
68.68%
13.78
7.02%
14.90
8.15%
18.65
25.13%
18.83
0.97%
ev to sales
3.20
-
4.35
35.86%
3.48
20.13%
5.19
49.26%
3.75
27.68%
3.35
10.67%
2.50
25.40%
3.31
32.46%
2.65
20.08%
3.00
13.35%
free cash flow per share
4.09
-
4.70
14.90%
9.98
112.39%
-15.91
259.35%
-1.27
92.02%
17.83
1,503.77%
15.64
12.25%
23.82
52.31%
8.81
63.04%
16.32
85.37%
free cash flow yield
0.02
-
0.01
32.39%
0.03
133.47%
-0.04
214.25%
-0.00
90.84%
0.05
1,670.14%
0.06
13.03%
0.05
7.68%
0.03
53.24%
0.03
31.42%
graham net net
-19.62
-
-16.09
17.97%
-13.06
18.82%
-36.88
182.30%
-33.44
9.32%
-57.56
72.12%
-56.74
1.42%
-28.79
49.26%
3.88
113.48%
3.72
4.08%
graham number
77.03
-
102.39
32.92%
132.27
29.18%
149.09
12.72%
182.58
22.46%
203.04
11.20%
161.89
20.27%
243.95
50.69%
291.38
19.44%
273.99
5.97%
income quality
0.94
-
0.69
26.98%
0.94
36.58%
0.84
10.82%
0.40
52.51%
1.21
204.31%
1.68
38.47%
1.44
13.98%
0.40
72.10%
1.04
158.89%
intangibles to total assets
0.12
-
0.10
14.60%
0.11
10.22%
0.16
42.20%
0.15
8.83%
0.30
103.59%
0.29
4.79%
0.28
3.69%
0.23
15.26%
0.23
2.01%
interest coverage
9.18
-
26.83
192.30%
50.85
89.53%
27.04
46.82%
21.97
18.76%
12.19
44.50%
6.45
47.13%
16.68
158.68%
23.53
41.12%
25.59
8.73%
interest debt per share
27.45
-
26.44
3.69%
24.25
8.27%
51.42
112.00%
53.84
4.70%
79.02
46.78%
81.44
3.06%
46.57
42.81%
42.35
9.08%
13.04
69.20%
inventory turnover
2.06
-
2.16
4.47%
2.38
10.62%
2.02
15.44%
1.82
9.69%
1.84
1.14%
1.85
0.26%
1.69
8.29%
1.56
7.61%
1.85
18.17%
invested capital
0.79
-
0.62
20.58%
0.46
26.83%
0.75
63.97%
0.62
17.36%
0.76
23.01%
0.77
1.55%
0.35
54.08%
0.25
29.99%
0.07
72.53%
market cap
209.86B
-
356.63B
69.94%
324.42B
9.03%
452.49B
39.48%
394.19B
12.88%
352.42B
10.60%
273.60B
22.37%
451.37B
64.98%
356.77B
20.96%
499.24B
39.93%
net current asset value
-9.49B
-
-4.00B
57.88%
-914M
77.14%
-20.82B
2,178.23%
-9.00B
56.77%
-33.06B
267.27%
-32.61B
1.36%
-2.39B
92.67%
35.20B
1,572.10%
39.48B
12.17%
net debt to ebitda
1.68
-
1.10
34.57%
0.71
35.44%
1.84
159.66%
1.40
24.12%
2.46
75.66%
2.58
4.92%
1.16
54.99%
1.04
10.38%
0.17
83.19%
net income per share
7.85
-
11.22
42.92%
14.87
32.57%
14.53
2.29%
17.35
19.37%
18.06
4.11%
11.49
36.36%
20.84
81.34%
22.72
9.04%
19.35
14.87%
operating cash flow per share
8.66
-
9.71
12.02%
19.48
100.66%
13.18
32.32%
8.98
31.88%
28.15
213.53%
24.47
13.08%
32.17
31.44%
20.55
36.10%
26.47
28.81%
payables turnover
3.10
-
3.03
2.05%
2.57
15.21%
2.17
15.54%
2.30
5.85%
2.57
11.95%
2.54
1.52%
2.48
2.02%
2.72
9.57%
2.97
9.09%
receivables turnover
4.93
-
4.57
7.42%
4.80
5.04%
3.88
19.14%
3.20
17.62%
2.68
16.14%
3.02
12.57%
3.41
12.94%
2.95
13.53%
3.81
29.44%
research and ddevelopement to revenue
0.01
-
0.01
58.57%
0.01
11.98%
0.02
8.39%
0.01
4.78%
0.01
41.87%
0.01
23.27%
0.01
23.01%
0.01
3.25%
0.01
4.10%
return on tangible assets
0.11
-
0.14
23.68%
0.17
21.17%
0.12
32.01%
0.12
1.12%
0.11
2.40%
0.07
38.18%
0.12
77.21%
0.11
11.45%
0.10
9.41%
revenue per share
70.56
-
84.51
19.76%
96.09
13.71%
92.11
4.15%
113.30
23.01%
124.53
9.91%
134.92
8.34%
144.78
7.31%
144.84
0.04%
166.18
14.73%
roe
0.23
-
0.27
15.60%
0.28
5.32%
0.21
24.87%
0.20
4.99%
0.18
12.35%
0.11
36.29%
0.16
44.82%
0.14
16.67%
0.11
18.03%
roic
0.15
-
0.18
21.16%
0.20
10.49%
0.12
40.61%
0.12
6.06%
0.10
19.83%
0.09
9.83%
0.14
59.46%
0.10
26.85%
0.14
31.98%
sales general and administrative to revenue
0.02
-
0.02
17.57%
0.02
15.28%
0.03
10.49%
0.02
9.11%
0.03
12.52%
0.04
47.82%
0.03
19.11%
0.03
9.36%
0.03
19.62%
shareholders equity per share
33.59
-
41.53
23.63%
52.28
25.88%
67.99
30.05%
85.42
25.64%
101.45
18.78%
101.35
0.10%
126.91
25.22%
166.05
30.84%
172.46
3.86%
stock based compensation to revenue
tangible asset value
26.17B
-
34.86B
33.19%
43.47B
24.70%
46.51B
7.01%
62.69B
34.77%
46.21B
26.28%
49.32B
6.72%
83.47B
69.23%
125.62B
50.50%
137.93B
9.80%
tangible book value per share
25.56
-
34.05
33.19%
42.46
24.70%
45.44
7.01%
61.23
34.77%
45.14
26.28%
48.18
6.72%
81.53
69.23%
122.71
50.50%
135.81
10.68%
working capital
6.40B
-
9.62B
50.35%
10.30B
7.14%
7.17B
30.47%
22.47B
213.59%
11.56B
48.57%
4.46B
61.41%
8.55B
91.64%
44.22B
417.37%
44.86B
1.44%

All numbers in (except ratios and percentages)